Jay Saccaro

Executive Vice President, Chief Financial Officer and Chief Operating Officer · Zoetis

Animal Health

Jay Saccaro leads Zoetis’ finance and operations functions after CFO roles at GE HealthCare, Baxter and Hill-Rom.

Last reviewed: Nov 2, 2026

Jay Saccaro

Executive Vice President, Chief Financial Officer and Chief Operating Officer
Zoetis

Last Reviewed: November 2, 2026

Executive Summary

Jay Saccaro leads Zoetis’ finance and operations functions after CFO roles at GE HealthCare, Baxter and Hill-Rom.

Career Highlights

  • Became Zoetis CFO and COO on August 17, 2026.
  • Previously led finance at GE HealthCare and Baxter.
  • Began his career in strategic planning at The Walt Disney Company.

Professional Journey

Saccaro began his career in strategic planning at The Walt Disney Company. His early strategy and business development work also included Clear Channel Communications. In 2002, he joined Baxter International as manager of strategy for its BioScience business. He later held vice president roles in strategy, financial planning and finance for Europe, the Middle East and Africa before becoming corporate vice president and treasurer in 2011.

He moved to Hill-Rom as senior vice president and CFO in 2013. Returning to Baxter in 2014, he initially served as special assistant to the CEO before becoming CFO in 2015. His finance leadership encompassed the company’s post-spinoff transformation, margin improvement work and capital structure optimization.

In June 2023, Saccaro became vice president and CFO of GE HealthCare. He led financial processes and capital allocation work for the recently independent public company, with responsibilities also encompassing information technology, strategy and business development. His work included financial approaches to new product planning and research investment priorities.

He remained with GE HealthCare through August 14, 2026, supporting the transition to an interim CFO. Three days later, he joined Zoetis as executive vice president, CFO and COO. The combined role placed global manufacturing and supply alongside his responsibilities for capital allocation, financial strategy, reporting, controls and investor engagement. His current operating portfolio also includes procurement.